NUDT1 and acute myeloid leukemia: In addition, Centio et al. used the inv(16)/KITD816Y AML mouse model, mimicking the genetics of acute myelocytic leukemia (AML) patients exhibiting a poor response to standard chemotherapy, to explore the effects of a combination of MTH1 inhibitor TH1579 with ROS-inducing chemotherapy.